Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction

[1]  S. Taylor,et al.  Comparison of haemodynamic dose-response effects of beta- and alpha-beta-blockade in acute myocardial infarction. , 1984, International journal of cardiology.

[2]  A. J. Man in 't Veld,et al.  Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension. , 1983, European heart journal.

[3]  R. Peto,et al.  Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction. , 1983, Circulation.

[4]  S. Taylor,et al.  Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease. , 1982, European heart journal.

[5]  J. Kjekshus,et al.  Timolol‐related Reduction in Mortality and Reinfarction in Patients Ages 65‐75 Years Surviving Acute Myocardial Infarction , 1982, Circulation.

[6]  G. Sutton,et al.  A long-term prevention study with oxprenolol in coronary heart disease. , 1982, The New England journal of medicine.

[7]  S. Taylor,et al.  Haemodynamic advantages of combined alpha-blockade and beta-blockade over beta-blockade alone in patients with coronary heart disease. , 1982, British medical journal.

[8]  B. J. Clark,et al.  Pindolol--the pharmacology of a partial agonist. , 1982, British journal of clinical pharmacology.

[9]  S. Carruthers.  Cardiac dose-response relationships of oral and intravenous pindolol. , 1982, British journal of clinical pharmacology.

[10]  S. Taylor,et al.  Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful? , 1982, The New England journal of medicine.

[11]  S. Taylor,et al.  Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man. , 1981, British journal of clinical pharmacology.

[12]  S. Taylor,et al.  HAEMODYNAMIC EFFECTS OF BETA-BLOCKADE IN ISCHAEMIC HEART FAILURE , 1981, The Lancet.

[13]  K. Swedberg,et al.  EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION A Double-blind Randomised Trial , 1981, The Lancet.

[14]  O. Hartling,et al.  Adrenergic beta receptor blockade: Hemodynamic importance of intrinsic sympathomimetic activity at rest , 1981, Clinical pharmacology and therapeutics.

[15]  R. Peto,et al.  EARLY INTRAVENOUS ATENOLOL TREATMENT IN SUSPECTED ACUTE MYOCARDIAL INFARCTION Preliminary Report of a Randomised Trial , 1980, The Lancet.

[16]  P. Cryer,et al.  Rapid activation of the sympathetic nervous system following coronary artery occlusion: relationship to infarct size, site, and haemodynamic impact. , 1979, Cardiovascular research.

[17]  W. M. Smith,et al.  PROTECTIVE EFFECT OF PROPRANOLOL IN THREATENED MYOCARDIAL INFARCTION , 1978, The Lancet.

[18]  T. Peter,et al.  Reduction of Enzyme Levels by Propranolol After Acute Myocardial Infarction , 1978, Circulation.

[19]  H. Gold,et al.  Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction. , 1976, The American journal of cardiology.

[20]  Glatt Mm,et al.  Letter: Scientific medicine. , 1974 .

[21]  D. Reid,et al.  Inhibition by -blockade of the ST segment elevation after acute myocardial infarction in man. , 1972, Cardiovascular research.

[22]  J. Covell,et al.  Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions , 1971, Circulation.

[23]  J. Shillingford,et al.  The circulatory effects of practolol (ICI 50172) in patients with acute myocardial infarction. , 1970, Cardiovascular research.

[24]  E. Braunwald.  Thirteenth Bowditch lecture. The determinants of myocardial oxygen consumption. , 1969, The Physiologist.

[25]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.

[26]  J. Winch.  Employers' liability for cancer of the scrotum. , 1968, Lancet.

[27]  J. Shillingford,et al.  Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction. , 1967, The American journal of cardiology.

[28]  E. Sivertssen,et al.  Haemodynamic effects of propranolol (Inderal) in acute myocardial infarction. , 1967, British medical journal.

[29]  J. Ross,et al.  Velocity of contraction as a determinant of myocardial oxygen consumption. , 1965, The American journal of physiology.

[30]  P. Snow.  Effect of propranolol in myocardial infarction. , 1965, Lancet.

[31]  S. Taylor,et al.  Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction? , 2004, European Journal of Clinical Pharmacology.

[32]  S. Taylor,et al.  Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease , 2004, European Journal of Clinical Pharmacology.

[33]  J. Shillingford.  Inhibition by beta-blockade of the ST segment elevation after acute myocardial infarction in man. , 2000, Cardiovascular research.

[34]  A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. , 1982, JAMA.

[35]  W. J. Dixon,et al.  BMDP-77, Biomedical Computer Programs, P-Series , 1979 .

[36]  D. Reid,et al.  Electrocardiographic surface mapping of the heart following myocardial infarction and the influence of beta-blockade. , 1976, Postgraduate medical journal.

[37]  S. Ayres,et al.  Propranolol in acute myocardial infarction in man: effects of haemodynamics and myocardial oxygenation. , 1976, Postgraduate medical journal.

[38]  C. Ansell.  Letter: Milk for babies. , 1975, Lancet.

[39]  W. Dixon.  BMD : biomedical computer programs , 1967 .